Unknown

Dataset Information

0

Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

ABSTRACT:

SUBMITTER: Dunser MW 

PROVIDER: S-EPMC5542935 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline.
| S-EPMC5738558 | biostudies-literature
Unknown Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).
| S-EPMC4091463 | biostudies-literature
Unknown Angiotensin II in septic shock.
| S-EPMC4360936 | biostudies-literature
Unknown Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin.
| S-EPMC5751302 | biostudies-literature
Unknown Angiotensin II: a new therapeutic option for vasodilatory shock.
| S-EPMC6067786 | biostudies-literature
Unknown Survival after shock requiring high-dose vasopressor therapy.
| S-EPMC3590882 | biostudies-other
Unknown Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
| S-EPMC7006163 | biostudies-literature
Unknown Does vasopressor therapy have an indication in hemorrhagic shock?
| S-EPMC3691630 | biostudies-literature
Unknown Release of purine and pyrimidine nucleosides and their catabolites from the perfused rat hindlimb in response to noradrenaline, vasopressin, angiotensin II and sciatic-nerve stimulation.
| S-EPMC1131205 | biostudies-other
Unknown Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
| S-EPMC7856533 | biostudies-literature